167 related articles for article (PubMed ID: 36621290)
1. Contemplating immunopeptidomes to better predict them.
Gfeller D; Liu Y; Racle J
Semin Immunol; 2023 Mar; 66():101708. PubMed ID: 36621290
[TBL] [Abstract][Full Text] [Related]
2. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
Front Immunol; 2018; 9():1795. PubMed ID: 30127785
[TBL] [Abstract][Full Text] [Related]
3. NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions.
Alvarez B; Reynisson B; Barra C; Buus S; Ternette N; Connelley T; Andreatta M; Nielsen M
Mol Cell Proteomics; 2019 Dec; 18(12):2459-2477. PubMed ID: 31578220
[TBL] [Abstract][Full Text] [Related]
4. Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes.
Racle J; Guillaume P; Schmidt J; Michaux J; Larabi A; Lau K; Perez MAS; Croce G; Genolet R; Coukos G; Zoete V; Pojer F; Bassani-Sternberg M; Harari A; Gfeller D
Immunity; 2023 Jun; 56(6):1359-1375.e13. PubMed ID: 37023751
[TBL] [Abstract][Full Text] [Related]
5. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
Zhao W; Sher X
PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
[TBL] [Abstract][Full Text] [Related]
6. Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data.
Reynisson B; Barra C; Kaabinejadian S; Hildebrand WH; Peters B; Nielsen M
J Proteome Res; 2020 Jun; 19(6):2304-2315. PubMed ID: 32308001
[TBL] [Abstract][Full Text] [Related]
7. Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8
Gfeller D; Schmidt J; Croce G; Guillaume P; Bobisse S; Genolet R; Queiroz L; Cesbron J; Racle J; Harari A
Cell Syst; 2023 Jan; 14(1):72-83.e5. PubMed ID: 36603583
[TBL] [Abstract][Full Text] [Related]
8. How to Predict Binding Specificity and Ligands for New MHC-II Alleles with MixMHC2pred.
Racle J; Gfeller D
Methods Mol Biol; 2024; 2809():215-235. PubMed ID: 38907900
[TBL] [Abstract][Full Text] [Related]
9. Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).
Koumantou D; Barnea E; Martin-Esteban A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Pratsinis H; Georgiadis D; Stern LJ; Admon A; Stratikos E
Cancer Immunol Immunother; 2019 Aug; 68(8):1245-1261. PubMed ID: 31222486
[TBL] [Abstract][Full Text] [Related]
10. Integral Use of Immunopeptidomics and Immunoinformatics for the Characterization of Antigen Presentation and Rational Identification of BoLA-DR-Presented Peptides and Epitopes.
Fisch A; Reynisson B; Benedictus L; Nicastri A; Vasoya D; Morrison I; Buus S; Ferreira BR; Kinney Ferreira de Miranda Santos I; Ternette N; Connelley T; Nielsen M
J Immunol; 2021 May; 206(10):2489-2497. PubMed ID: 33789985
[TBL] [Abstract][Full Text] [Related]
11. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
[TBL] [Abstract][Full Text] [Related]
12. FASTMAP-a flexible and scalable immunopeptidomics pipeline for HLA- and antigen-specific T-cell epitope mapping based on artificial antigen-presenting cells.
Weisbrod L; Capriotti L; Hofmann M; Spieler V; Dersch H; Voedisch B; Schmidt P; Knake S
Front Immunol; 2024; 15():1386160. PubMed ID: 38779658
[TBL] [Abstract][Full Text] [Related]
13. Benchmarking predictions of MHC class I restricted T cell epitopes in a comprehensively studied model system.
Paul S; Croft NP; Purcell AW; Tscharke DC; Sette A; Nielsen M; Peters B
PLoS Comput Biol; 2020 May; 16(5):e1007757. PubMed ID: 32453790
[TBL] [Abstract][Full Text] [Related]
14. The MHC Motif Atlas: a database of MHC binding specificities and ligands.
Tadros DM; Eggenschwiler S; Racle J; Gfeller D
Nucleic Acids Res; 2023 Jan; 51(D1):D428-D437. PubMed ID: 36318236
[TBL] [Abstract][Full Text] [Related]
15. Construction and Screening of an Antigen-Derived Peptide Library Displayed on Yeast Cell Surface for CD4+ T Cell Epitope Identification.
Wen F; Smith MR; Zhao H
Methods Mol Biol; 2019; 2024():213-234. PubMed ID: 31364052
[TBL] [Abstract][Full Text] [Related]
16. Precision Neoantigen Discovery Using Large-Scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation.
Pyke RM; Mellacheruvu D; Dea S; Abbott C; Zhang SV; Phillips NA; Harris J; Bartha G; Desai S; McClory R; West J; Snyder MP; Chen R; Boyle SM
Mol Cell Proteomics; 2023 Apr; 22(4):100506. PubMed ID: 36796642
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the immunological effects of 5-azacytidine treatment in patients with myelodysplastic syndrome and identifying new conditional ligands and T-cell epitopes of relevance in melanoma.
Frøsig TM
Dan Med J; 2015 Aug; 62(8):B5144. PubMed ID: 26239596
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex linked databases and prediction tools for designing vaccines.
Singh SP; Mishra BN
Hum Immunol; 2016 Mar; 77(3):295-306. PubMed ID: 26585361
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
20. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
